US2007148630A1PendingUtilityA1
Removal of Adenine During a Pathogen Reduction Process in Whole Blood or Red Blood Cells by Dilution
Est. expiryApr 24, 2022(expired)· nominal 20-yr term from priority
A61P 7/08A61L 2103/09A61L 2/18A61L 2/02A61L 2/16A61K 41/17A01N 43/90A61L 2/084A61K 35/18A61L 2/10A61L 2/08A61L 2103/05A01N 1/168A01N 1/124A01N 1/12
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The methods of this invention involve preventing the formation of a complex between adenine and riboflavin by reducing the amount of adenine in a solution containing blood or blood components to be pathogen reduced.
Claims
exact text as granted — not AI-modified1 . A method for treating a selected quantity of fluid to reduce pathogens which may be present therein, the fluid containing one or more components selected from the group consisting of blood and blood components, the method comprising:
(a) adding a sufficient volume of a washing solution to the selected quantity of fluid; (b) washing the selected quantity of fluid to create a washed fluid; (c) mixing a pathogen reduction-effective, substantially non-toxic amount of 7,8-dimethyl-10-ribityl isoalloxazine photosensitizer with the washed fluid; (d) exposing the washed fluid containing the photosensitizer to photoradiation of sufficient wavelength and energy to activate the photosensitizer, whereby the pathogens are reduced.
2 . The method of claim 1 wherein the washing step further comprises a plurality of washing steps.
3 . The method of claim 1 wherein the method substantially prevents damage to the blood or blood components contained in the fluid by reducing the concentration of adenine in the fluid to prevent formation of a photosensitizer-adenine complex.
4 . The method of claim 1 wherein the method substantially prevents an increase in oxidation reactions produced by photolysis of the photosensitizer.
5 . The method of claim 1 wherein the mixing step further comprises placing the fluid in a container transparent to photoradiation, adding the photosensitizer to the fluid in the container and agitating the container.
6 . The method of claim 1 wherein the washed fluid consists essentially of platelets.
7 . The method of claim 1 wherein the washed fluid consists essentially of red blood cells.
8 . A fluid for pathogen reduction that is substantially adenine-free comprising:
one or more components selected from the group consisting of blood and blood components; an endogenous photosensitizer or an endogenously-based derivative photosensitizer and an adenine-free solution.Join the waitlist — get patent alerts
Track US2007148630A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.